| Jennifer Delutio Inc | |
|
231 Se Barrington Dr, Suite 202, Oak Harbor, WA 98277 | |
| (360) 279-1905 | |
| (360) 279-9459 |
| Full Name | Jennifer Delutio Inc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 231 Se Barrington Dr, Oak Harbor, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437133469 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL00003361 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Delutio Inc 2011 Bradley Dr, Anacortes, WA 98221 Ph: (360) 720-9685 | Jennifer Delutio Inc 231 Se Barrington Dr, Suite 202, Oak Harbor, WA 98277 Ph: (360) 279-1905 |
News Archive
West Virginia's Medicaid patients are nearing a crisis when it comes to access to dental care, West Virginia Public Broadcasting reports. Medicaid's reimbursement rates for dentistry haven't increased since 1991, and West Virginia cut rates in 1994 by 30 percent, causing fewer and fewer dentists to accept payment from the public program for low-income patients.
Pro-Pharmaceuticals, Inc., today announced that it has closed a $335,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. This tranche brings the total raised to date from the 10X Fund to approximately $5.1 million.
Hovione announced today it has filed its first Investigational New Drug (IND) Application with the U.S. Food and Drug Administration. This event represents a milestone in Hovione's strategy of developing improved drug delivery options for established drugs.
A Cedars-Sinai physician-scientist has been awarded a $3 million grant from the California Institute for Regenerative Medicine to study with new stem cell technology Charcot-Marie-Tooth disease, the most common inherited neurological disorder and which damages nerves that control muscles.
Celsion Corporation announced today that it has completed a critical regulatory step in the countries of China and Japan to rapidly enroll patients in its global Phase III ThermoDox trial for the treatment of Hepatocellular Carcinoma (HCC), also known as primary liver cancer.
› Verified 9 days ago
Alyssa Beth Gibson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 S Oak Harbor St, Oak Harbor, WA 98277 Phone: 360-279-5009 | |
Blessed By Nature Therapy And Learning Center Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1476 Boon Hollow Ln, Oak Harbor, WA 98277 Phone: 206-949-2859 | |
Jean H Vandongen, M.ED.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 151 Se Midway Blvd, Oak Harbor, WA 98277 Phone: 360-279-5100 | |
Emily Lynn Harris, CF SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 380 Ne Regatta Dr, Oak Harbor, WA 98277 Phone: 360-279-5197 | |
Jennifer Klassen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 S Oak Harbor St, Oak Harbor, WA 98277 Phone: 360-279-5187 | |
Sara Kaye Burch-wilhelm, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 950 Se Regatta Dr # 101, Oak Harbor, WA 98277 Phone: 360-679-1039 Fax: 360-679-6646 | |
Mrs. Cathleen Marie Queeno-wall, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 67 Ne Izett St, Oak Harbor, WA 98277 Phone: 360-279-5544 Fax: 360-279-5070 |